1200133-34-1

Basic information

• Product Name: VCH-916
• Synonyms: VCH-916;5-(1-Cyclohexen-1-yl)-3-[(trans-4-methoxycyclohexyl)[(trans-4-methylcyclohexyl)carbonyl]amino]-2-thiophenecarboxylic acid potassium salt;potassiuM 5-cyclohexenyl-3-(N-((1r,4r)-4-Methoxycyclohexyl)-4-MethylcyclohexanecarboxaMido)thiophene-2-carboxylate;VCH-916, >=98%
• CAS NO: 1200133-34-1
• Molecular Formula: C26H36KNO4S
• Molecular Weight: 497.73164
• EINECS: -0
• Mol File: 1200133-34-1.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: VCH-916(CAS DataBase Reference)
• NIST Chemistry Reference: VCH-916(1200133-34-1)
• EPA Substance Registry System: VCH-916(1200133-34-1)

Safety Data

• Hazardous Substances Data: 1200133-34-1(Hazardous Substances Data)

Usage

General Description

VCH-916 is a chemical compound belonging to the class of indene-based vascular disrupting agents (VDAs), which are designed to selectively attack tumor blood vessels and cut off the blood supply to the tumor, ultimately leading to tumor cell death. VCH-916 has shown promising results in preclinical studies, demonstrating potent anti-tumor activity and low toxicity to normal tissues. VCH-916 is also being investigated for its potential use in combination with other cancer treatments, such as chemotherapy and radiation therapy, to enhance their effectiveness. VCH-916 represents a novel approach to cancer therapy by targeting the vasculature of tumors, and ongoing research is focused on its development as a potential new treatment for various types of cancer.